Source:http://linkedlifedata.com/resource/pubmed/id/18034994
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2007-11-23
|
pubmed:abstractText |
Cardiac hypertrophy is an independent risk factor for heart failure. Recent studies on gene regulation of proteins have involved intracellular Ca2+ homeostasis. The Ca2+-sensitive phosphatase, calcineurin, is one potential regulator of the hypertrophic response, so we aimed to investigate the calcineurin-dependent signal pathway at different stages of hypertrophy in human myocardium. We found the calcineurin pathway to be significantly activated in hypertrophic compared with non-hypertrophic myocardium as demonstrated by increased calcineurin activity and expression of calcineurin A-beta and B, and GATA-4, and a shift of phosphorylated cytoplasmic NFAT-3 into the nucleus as dephosphorylated nuclear NFAT-3. There was a tendency for these changes to be more pronounced in the decompensated compared with the compensated hypertrophic myocardium. The present study provides evidence for significant activation of the Ca2+-triggered calcineurin pathway in hypertrophic humans. Already present in compensated hypertrophy it showed a tendency to a further increase following transition to decompensated hypertrophy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcineurin,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/GATA4 Transcription Factor,
http://linkedlifedata.com/resource/pubmed/chemical/NFATC Transcription Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Isoforms
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0300-0605
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
803-18
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:18034994-Adult,
pubmed-meshheading:18034994-Aged,
pubmed-meshheading:18034994-Aged, 80 and over,
pubmed-meshheading:18034994-Animals,
pubmed-meshheading:18034994-Calcineurin,
pubmed-meshheading:18034994-Calcium,
pubmed-meshheading:18034994-Female,
pubmed-meshheading:18034994-GATA4 Transcription Factor,
pubmed-meshheading:18034994-Heart Failure,
pubmed-meshheading:18034994-Humans,
pubmed-meshheading:18034994-Hypertrophy,
pubmed-meshheading:18034994-Male,
pubmed-meshheading:18034994-Middle Aged,
pubmed-meshheading:18034994-Myocardium,
pubmed-meshheading:18034994-NFATC Transcription Factors,
pubmed-meshheading:18034994-Protein Isoforms,
pubmed-meshheading:18034994-Risk Factors,
pubmed-meshheading:18034994-Signal Transduction
|
pubmed:articleTitle |
Activation of the calcineurin/NFAT signalling cascade starts early in human hypertrophic myocardium.
|
pubmed:affiliation |
Laboratory of Muscle Research and Molecular Cardiology, Department of Internal Medicine, University of Cologne, Cologne, Germany. Holger.Diedrichs@uni-koeln.de
|
pubmed:publicationType |
Journal Article
|